HPV vaccination is preventing future cancer deaths.
A prevention tool is changing what cervical cancer could mean for a generation.
Good outcome probability
HPV vaccination will remain a component of routine immunization programmes in at least 29 African countries through 2027.
There is a quieter side of preventive medicine: a child is vaccinated today against a cancer that might otherwise emerge decades later.
WHO Africa has highlighted the gains of HPV immunization, while warning that health financing remains uncertain. Prevention is not the same as universal access.
The scale of future benefit will be determined by sustained programmes, public trust and the ability to reach children in communities most often left behind.
What this could mean.
- Why this could be good
- Vaccinating against HPV helps prevent infections that cause most cervical cancers.
- Potential positive outcomes
More women could avoid preventable cervical cancer later in life.
Health systems may reduce long-term treatment costs and suffering.
Sustained access and screening remain essential for equity.
The assessment.
- What we are forecasting
- HPV vaccination will remain a component of routine immunization programmes in at least 29 African countries through 2027.
- Time horizon
- Through December 2027
- Editorial confidence in the evidence: 91%
- WHO Africa reported measurable HPV vaccination progress in 29 African countries by April 2026.
- What could change the outcome
- Funding disruptions or service interruptions could affect programme continuity.
The evidence.
- Routine vaccine systems deliver gains against cancer and malaria ↗World Health Organization Regional Office for Africa · April 2026
Read more.
- Low-carbon electricity grew faster than demand.Oct 14, 2026
- Electric cars are already displacing oil demand.Oct 14, 2026
- The high seas finally have a legal framework.Oct 14, 2026